Leveraging death of drug-sensitive cancer cells to promote immune-mediated bystander killing of subclones of drug-resistant tumour cells
Mona Tomaschko(The Francis Crick Institute), Julian Downward(The Francis Crick Institute)
Cited by 0
Related Papers
Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences
|Nature|1984|2.5k
Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease
|Human Molecular Genetics|2005|566
ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1
|Nature Cell Biology|2014|152
Therapeutic KRAS <sup>G12C</sup> inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers
|Science Advances|2022|134
Regulation of Akt(ser473) phosphorylation by Choline kinase in breast carcinoma cells
|Molecular Cancer|2009|72